Surgery Partners Q1 revenue beats estimates but issues weakest full-year guidance among peers

StockStory··Read original
2▲1 ▼2Impact / 5
Summary · why it matters

Surgery Partners reported first-quarter revenues of $810.9 million, up 4.5% year on year and exceeding analyst expectations by 1.6%, while also beating earnings per share estimates. However, the company delivered the weakest full-year guidance update among the seven outpatient and specialty care stocks tracked, a group that collectively beat revenue consensus by 1.9% and saw next-quarter guidance come in 5.9% above expectations. Shares of Surgery Partners have risen 2.5% since the report to $14.56. The broader peer group has averaged a 50.3% share price gain since their latest earnings, with agilon health surging 309% after posting the highest guidance raise, while U.S. Physical Therapy fell 14% after the weakest performance against analyst estimates.

Impact on assets 5

Health Care▼ · 3 stocks
Surgery Partners Inc
SGRY
▼ NegativeCapitalrelevance

Surgery Partners issued the weakest full-year guidance among peers, despite beating Q1 estimates.

Aging Population▲ · 2 stocks
agilon health Inc
AGL
▲ PositiveCapitalrelevance

agilon health posted the highest guidance raise among peers, surging 309% since its latest earnings.